Long-Term Impact of Diabetes in Pregnancy on Human Offspring Metabolism

Author(s):  
Louise Kelstrup ◽  
Tine Dalgaard Clausen ◽  
Azadeh Houshmand-Oeregaard ◽  
Elisabeth R. Mathiesen ◽  
Peter Damm
2018 ◽  
Vol 145 ◽  
pp. 155-166 ◽  
Author(s):  
Jean-Baptiste Armengaud ◽  
Ronald C.W. Ma ◽  
Benazir Siddeek ◽  
Gerard H.A. Visser ◽  
Umberto Simeoni

2018 ◽  
Vol 47 (3) ◽  
pp. 928-937 ◽  
Author(s):  
Rebecca C Richmond ◽  
Gemma C Sharp ◽  
Georgia Herbert ◽  
Charlotte Atkinson ◽  
Caroline Taylor ◽  
...  

2019 ◽  
pp. 201-222
Author(s):  
Louise Kelstrup ◽  
Birgitte Bytoft ◽  
Line Hjort ◽  
Azadeh Houshmand-Oeregaard ◽  
Elisabeth R. Mathiesen ◽  
...  

2008 ◽  
Vol 19 (3) ◽  
pp. 245-269 ◽  
Author(s):  
RINAT GABBAY BEN-ZIV ◽  
MOSHE HOD

Gestational diabetes (GDM) is defined as “carbohydrate intolerance of variable severity with onset or first recognition during pregnancy.” The definition is applicable regardless of whether insulin is used for treatment or the condition persists after pregnancy. It does not exclude the possibility that unrecognized glucose intolerance may have antedated the pregnancy”. GDM complicates 3–15% of all pregnancies and is a major cause of perinatal morbidity and mortality, as well as maternal long term morbidity. Of all types of diabetes, gestational diabetes (GDM) accounts for approximately 90–95% of all cases of diabetes in pregnancy.


2018 ◽  
Vol 4 (2) ◽  
pp. 145-149
Author(s):  
Sharmin Jahan ◽  
MA Hasanat

Hyperglycemia is the most common endocrine disorder of pregnancy. As compared to Diabetes in pregnancy(DIP) the management of gestational DM(GDM) has always been a topic of controversy. Medical nutrition therapy(MNT) is the cornerstone of GDM management. 80-90% of GDM mothers can be treated by MNT alone and the rest will require drugs. Considerable controversy surrounds the use of oral anti-diabetic medications in pregnancy. The most widely studied drugs are glyburide and metformin. Conflicting results have been produced by different studies. However recent meta-analyses have shown that they can be an attractive alternative to insulin if long term safety data become available. Till then it might be too early to make a final comment on their use in GDM.Journal of National Institute of Neurosciences Bangladesh, 2018;4(2): 145-149


Sign in / Sign up

Export Citation Format

Share Document